Session » Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics III
-
Abstract Number: 2980
Chemokine CCL21 As a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
-
Abstract Number: 2981
Evaluation of American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis (CRISS) in the Fasscinate Trial
-
Abstract Number: 2982
Morbidity and Mortality of Scleroderma in African Americans
-
Abstract Number: 2983
Predictors for Disease Worsening Defined By Organ Failure in Diffuse Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis
-
Abstract Number: 2984
Predictive Value of a Combined Index for Weight Loss in Systemic Sclerosis